Focused on PhIII, BeiGene touts early PD-1 results; Amgen partners with Simcere on China biosimilars work
→ Hustling as fast as it can, BeiGene $BGNE today offered an early look at early-stage data for its PD-1 checkpoint partnered with Celgene …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
